CN103619405A - 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 - Google Patents

用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 Download PDF

Info

Publication number
CN103619405A
CN103619405A CN201280031279.9A CN201280031279A CN103619405A CN 103619405 A CN103619405 A CN 103619405A CN 201280031279 A CN201280031279 A CN 201280031279A CN 103619405 A CN103619405 A CN 103619405A
Authority
CN
China
Prior art keywords
pulse
hours
superthreshold
disease
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201280031279.9A
Other languages
English (en)
Other versions
CN103619405B (zh
Inventor
J·A·莱文
M·A·法尔蒂斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SetPoint Medical Corp
Original Assignee
SetPoint Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SetPoint Medical Corp filed Critical SetPoint Medical Corp
Publication of CN103619405A publication Critical patent/CN103619405A/zh
Application granted granted Critical
Publication of CN103619405B publication Critical patent/CN103619405B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36053Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04CROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2270/00Control; Monitoring or safety arrangements
    • F04C2270/04Force
    • F04C2270/042Force radial
    • F04C2270/0421Controlled or regulated

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本文描述了用于施加足以治疗慢性炎症的极低占空比刺激的方法和系统。尤其是,本文描述了足以导致对促炎细胞因子和/或慢性炎症的影响的持久(例如,>4小时、大于12小时、大于24小时、大于48小时)抑制的电刺激的单个超阈值脉冲。这些方法和设备对治疗炎症性肠病(IBD)尤其感兴趣。

Description

用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活
相关申请的交叉引用
本申请要求于2011年5月9日提交的美国临时申请61/484,112的利益,在此通过引用将其整体结合。本专利申请可以涉及下列专利和待决的专利申请中的任一项:于2009年5月1日提交并且题为“VAGUS NERVE STIMULATION ELECTRODES AND METHODSOF USE”的美国申请12/434,462;2009年11月17日提交并且题为“DEVICES AND METHODS FOR OPTIMIZING ELECTRODEPLACEMENT FOR ANTI-INFLAMMATORY STIMULATION”的美国申请12/620,413;2010年9月1日提交并且题为“PRESCRIPTION PADFOR TREATMENT OF INFLAMMATORY DISORDERS”的美国申请12/874,171;2010年11月1日提交并且题为“MODULATION OF THECHOLINERGIC ANTI-INFLAMMATORY PATHWAY TO TREATPAIN OR ADDICTION”的美国申请12/917,197;2010年12月23日提交并且题为“NEURAL STIMULATION DEVICES AND SYSTEMSFOR TREATMENT OF CHRONIC INFLAMMATION”的美国申请12/978,250;以及2010年6月9日提交并且题为“NERVE CUFF WITHPOCKET FOR LEADLESS STIMULATOR”的美国申请12/797,452。
通过引用的结合
本说明书中提及的所有出版物和专利申请通过引用整体结合于此,其程度如同每个单独的出版物或专利申请被特别地和单独地指示为通过引用结合。
技术领域
本发明总体上涉及用于使用极低占空比刺激来治疗包括慢性炎症和炎症性疾病(disorder)在内的疾病的系统和设备。尤其是,本文描述了用于治疗诸如肠道炎症性疾病之类的疾病的系统、设备和方法。本文总体上还描述了适于通过用于调整炎症性反应的极低占空比刺激对迷走神经(vagus nerve)进行电刺激以(经由烟碱性胆碱能抗炎通路(nicotinic cholinergic anti-inflammatory pathway))治疗慢性炎症的方法以及包括可植入微刺激器在内的设备。
背景技术
在文献中已经描述了神经胆碱能抗炎通路(CAP或NCAP)的电刺激,其开始于Kevin Tracey的开创性工作(例如,见Tracey KJ的“Physiology and immunology of the cholinergic antiinflammatorypathway”,The Journal of clinical investigation2007:117(2):289–96),他首次确认了胆碱能抗炎通路并且描述了迷走神经刺激与通过抑制细胞因子的产生的炎症的抑制之间的联系,从那以后,研究继续进行以探索CAP的刺激与炎症性疾病的调整之间的关系。通常的刺激参数已经包括了通过一阵脉冲(例如,在10Hz到1GHz之间持续30秒钟到20分钟)的刺激,具有在较高频率处看的效果的略微提高(例如,见Huston等人的US2009/0143831)。
尽管该工作已经暗示慢性炎症可以通过可植入刺激器成功地治疗,但是这样的长期地可植入和可用的刺激器的设计和实施已经证明是难懂的,部分地是由于能够真正长期使用的设备将面对的功率要求。
已经针对各种病症和疾病的治疗开发了可植入电刺激设备。例如,可植入心脏复律除颤器(ICD)已经用于治疗各种心脏疾病。脊髓刺激器(SCS)或脊柱刺激器(DCS)已经用于治疗包括背部手术失败综合征、复合性局部疼痛综合征和周围神经病在内的慢性疼痛疾病。周围神经刺激(PNS)系统已经用于治疗慢性疼痛综合征以及其他疾病和疾病。功能电刺激(FES)系统已经被用于在脊髓受伤患者中将某一功能恢复到否则瘫痪的四肢。
最近,已经开发了可植入的迷走神经刺激,包括用于治疗炎症的迷走神经刺激器。这样的植入物通常需要电极和电源。尺寸和用途限制的参数可以通常是功率要求,其要么要求持久的(并且因此通常大的)电池,要么要求充电电路和充电设备所增加的复杂化。
例如,通常的可植入电刺激系统可以包括引线上的一个或多个可编程电极,该可编程电极连接到可植入脉冲发生器(IPG),该可植入脉冲发生器包含电源和刺激电路。甚至相对小的可植入神经刺激器技术(即,具有附接到刺激器的本体的整体电极的微刺激器)可能也有这些缺点中的一些缺点,因为当前开发的无引线设备往往比期望的更大和更重,使得难以稳定地将这些设备相对于神经定位在合适的位置。
本文描述了令人惊讶的结果,即炎症的持久的、稳健的抑制可以通过在施加到迷走神经的单个(或非常少的)超阈值的电脉冲来实现。考虑到尽管施加最小功率却获得格外稳健的效果,该发现尤其令人惊讶,特别是与以高得多的施加的能量显示效果的公布的数据相比。这些发现支持用于治疗慢性炎症的各种极低功率的设备、系统和方法。尤其是,描述了用于治疗包括肠道的炎症性疾病(例如,肠易激症或IBD)在内的炎症性疾病的设备和方法,包括微刺激器以及基于所确认的显著低的功率要求使用微刺激器的方法。
发明内容
本文描述了用于迷走神经的格外低占空比刺激的设备、系统和方法。格外低、极低、超级低或超低占空比一般指的是使用每个时间周期的少数电脉冲和低刺激强度两者来提供刺激以使得占空比的功率要求非常低的占空比。下面是格外低、极低、超级低或超低占空比的各种实施例的示例。在一些实施例中,每4到48小时(以4小时为增量),电脉冲的数目可以介于1和5之间(以1个脉冲为增量)。在一些实施例中,刺激强度可以处于能够通过迷走神经影响所期望的生理反应的超阈值水平。在一些实施例中,超阈值水平介于大约100μA和5000μA之间,或者介于大约100μA和4000μA之间,或者介于大约100μA和3000μA之间,或者介于大约100μA和2000μA之间。在一些实施例中,超阈值水平小于大约2000μA、3000μA、4000μA或5000μA。
在一些实施例中,占空比是每4小时1个超阈值脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每4小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约3000μA。
在一些实施例中,脉冲宽度可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
在一些实施例中,提供用于治疗患者的慢性炎症和/或炎症性疾病的系统。该系统包括可植入微刺激器,被配置为向迷走神经施加低占空比刺激,其中低占空比刺激每4小时仅提供单个超阈值脉冲;以及控制器,被配置为设置用于微刺激器的剂量,其中该剂量包括被至少4小时的关断周期跟随的单个超阈值脉冲。在一些实施例中,关断周期是至少24小时,或者是至少48小时,或者介于大约4到48小时之间,或者介于大约12到48小时之间,或者介于大约24到48小时之间。在一些实施例中,单个超阈值脉冲具有小于5mA、小于3mA或者小于2mA的脉冲振幅。在一些实施例中,单个超阈值脉冲是双相的。在一些实施例中,慢性炎症是肠道炎症。在一些实施例中,慢性炎症是炎症性肠病。在一些实施例中,慢性炎症是克罗恩病(Crohn’sdisease)。
在一些实施例中,提供一种治疗患者的慢性炎症和/或炎症性疾病的方法。该方法包括:植入微刺激器;以及向迷走神经仅施加来自微刺激器的单个超阈值刺激脉冲,该单个超阈值刺激脉冲被至少4小时的关断时间跟随。在一些实施例中,关断时间是至少24小时,至少48小时,或者介于大约4到48小时之间,或者介于大约12到48小时之间,或者介于大约24到48小时之间。在一些实施例中,单个超阈值刺激脉冲具有小于5mA、小于3mA或者小于2mA的脉冲振幅。在一些实施例中,单个超阈值刺激脉冲是双相的。在一些实施例中,慢性炎症是肠道炎症。在一些实施例中,慢性炎症是炎症性肠病。在一些实施例中,慢性炎症是克罗恩病。
如本文所描述的可以被治疗的各种类型的炎症性疾病包括各种疾病状态,包括诸如枯草热、动脉粥样硬化、关节炎(类风湿、滑囊炎、痛风性关节炎、风湿性多肌痛等)、哮喘、自身免疫疾病、慢性炎症、慢性前列腺炎、肾小球肾炎、肾炎、炎症性肠病、盆腔炎性疾病、再灌注损伤、移植排斥、血管炎、心肌炎、结肠炎等疾病。
可以使用本发明治疗的炎症性疾病的非限制性示例包括:阑尾炎、消化性溃疡、胃溃疡、十二指肠溃疡、腹膜炎、胰腺炎、溃疡性结肠炎、伪膜性肠炎、急性结肠炎、缺血性结肠炎、憩室炎、会厌炎、失弛缓症、胆管炎、胆囊炎、肝炎、克罗恩病、肠炎、惠普尔病、过敏、过敏性休克、免疫复合物病、器官缺血、再灌注损伤、器官坏死、枯草热、脓毒症、败血症、内毒素性休克、恶病质、高热、嗜酸性肉芽肿、肉芽肿病、结节病、脓毒性流产、附睾炎、阴道炎、前列腺炎、尿道炎、支气管炎、肺气肿、鼻炎、肺炎、火山矽肺病(pneumoultramicroscopic silicovolcanoconiosis)、牙槽炎(alvealitis)、支气管炎、咽炎、胸膜炎、鼻窦炎、流感、呼吸道合胞病毒感染、HIV感染、乙型肝炎病毒感染、丙型肝炎病毒感染、疱疹病毒感染播散菌血症、登革热、念珠菌病、疟疾、丝虫病、变形虫病、包虫囊肿、烧伤、皮炎、皮肌炎、晒伤、荨麻疹、疣、风团、血管炎(vasulitis)、脉管炎、心内膜炎、动脉炎、动脉粥样硬化、血栓性静脉炎、心包炎、心肌炎、心肌缺血、结节性动脉周炎、风湿热、阿尔茨海默氏病、腹部疾病、充血性心脏衰竭、成人呼吸窘迫综合征、脑膜炎、脑炎、多发性硬化、脑梗塞、脑栓塞、格林-巴利综合征、神经炎、神经痛、脊髓损伤、瘫痪、葡萄膜炎、关节炎、关节痛、骨髓炎、筋膜炎、佩吉特氏病、痛风、牙周病、类风湿性关节炎、滑膜炎、重症肌无力、甲状腺炎、系统性红斑狼疮、古德帕斯彻氏综合征、白塞氏综合征、同种异体移植物排斥、移植物抗宿主病、一型糖尿病、二型糖尿病、强直性脊柱炎、伯杰氏病、赖特综合征、何杰金氏病、肠梗阻、高血压、肠易激综合征、心肌梗死、失眠、焦虑以及支架血栓。
附图说明
本发明的新特征与随后的权利要求中的特殊性一起被提出。通过参考下面提出说明性实施例(其中利用了本发明的原理)的详细描述以及附图,将获得本发明的特征和优点的更好的理解,其中:
图1是单个刺激波形的图形;
图2是将来自单个刺激脉冲的对TNF水平的影响与来自多达3000个脉冲的影响进行比较的曲线图;
图3是图示刺激后24小时来自单个刺激脉冲的对TNF水平的影响的曲线图;
图4是图示刺激后3小时和24小时来自单个刺激脉冲的对TNF水平的影响的曲线图;
图5是图示来自单个刺激脉冲的对IBD的大鼠模型中的损伤区域的影响的曲线图;以及
图6是图示来自单个刺激脉冲的对IBD的大鼠模型中的损伤区域的长期影响的曲线图。
具体实施方式
一般而言,本文描述了阐述用于治疗疾病的迷走神经的格外低占空比刺激的系统、方法和设备。尤其是,本文描述了阐述用于在哺乳动物模型中减少或防止炎症和炎症的影响的迷走神经的格外低占空比刺激的系统、方法和设备。格外低、极低、超级低或超低占空比一般指的是使用每个时间周期的少数电脉冲和低刺激强度两者来提供刺激以使得占空比的功率要求非常低的占空比。本文所描述的方法应用可以被用来显著减少炎症和/或炎症的影响的各种刺激方案。可以变化的刺激参数包括脉冲形状(例如,正弦的、方的、双相的、单相的等)、刺激的持续时间、导通时间、关断时间、脉间间隔,等等。本文检查的一个关键因素是超阈值脉冲的数目。如本文所示,即使当与多个刺激比较时,使用甚至单个超阈值刺激的迷走神经的刺激导致显著的和持久的影响。该影响当使用针对IBD的啮齿动物模型进行检查时尤为深刻。
下面是格外低、极低、超级低或超低占空比的各种实施例的示例。在一些实施例中,每4到48小时(以4小时为增量),电脉冲的数目可以介于1和5之间(以1个脉冲为增量)。在一些实施例中,刺激强度可以处于能够通过迷走神经影响所期望的生理反应的超阈值水平。在一些实施例中,超阈值水平介于大约100μA和5000μA之间,或者介于大约100μA和4000μA之间,或者介于大约100μA和3000μA之间,或者介于大约100μA和2000μA之间。在一些实施例中,超阈值水平小于大约2000μA、3000μA、4000μA或5000μA。
在一些实施例中,占空比是每4小时1个超阈值脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每4小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约3000μA。
本文所描述的示例使用被开发以用于驱动迷走神经刺激的刺激器和刺激控制包。在一些示例中,该刺激由软件包控制,该软件包被配置为在微处理器(例如个人计算机)上运行并且控制仿真器/刺激器(其可以称为ITE或集成终端仿真器)的输出。因此,本文所描述的系统可以包括可以是用于控制刺激的施加的软件、固件和/或硬件的逻辑(例如控制逻辑)。例如,在一些变化形式中,控制刺激和数据采集的参数可以包括:(1)包括阴极和阳极的选择的刺激电极对;(2)以1Hz为增量的频率;(3)脉冲宽度(PW):20-2,000μS(以1μS为增量);(4)脉冲振幅(PA):±0-5,000μA(以3μA为增量);以及(5)波形的A相和B相之间的脉间间隔(IPI):20-2,000μS(以1μS为增量)。
除了以上提供的示例性参数,在一些实施例中,PW可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
例如,图1上所示的示例性波形是双相的(电荷平衡的)波形100,其包括通过脉间间隔104(IPI)被隔开的两个对称的脉冲宽度102(PW)。脉冲宽度102具有脉冲振幅106(PA),其对于双相刺激的第一相108(A相)和第二相110(B相)也是对称的,且A相中是负脉冲振幅,而B相中是正振幅。可以使用其它脉冲波形。在一些实施例中,脉冲波形可以是非双相的并且/或者可以具有非对称的脉冲宽度和/或非对称的脉冲振幅。
刺激器可以在一对电极上生成脉冲串。这些脉冲可以使用双极电流源来生成,并且可以在两个电极输出上使用>1μF的陶瓷电容器来容性地隔离,恒流输出电压可以被设置为高达±18.8伏。
本文所描述的不同实验示例显示,迷走神经的合适的NCAP刺激可以用来限制或消除肠道炎症的影响,尤其在结肠炎的大鼠模型和克罗恩病的大鼠模型中。基于该数据,处于上述参数的双相刺激可以成功地治疗肠道炎症。
在一个示例中,小鼠(雄性,BALB/c)被麻醉,并且袖口电极(cuff electrode)(0.3mm ID,0.5mm电极间距离;微探针,Gaithersburg,MD)被置于左颈动脉鞘(包含颈迷走神经)周围且通过缝合来固定。超阈值脉冲(750μA,200μS,10Hz)以各种数目(0,1,10,100,300,600,3000)施加。后来,电极被移除并且关闭钉上的(stapled)伤口。小鼠恢复持续3小时,并且然后使用LPS(5mg/kg;IP)来进行挑战;这些小鼠在LPS之后90分钟牺牲,并且血清TNF通过ELISA测得,以测量对炎症性细胞因子的影响。如图2上所示,甚至单个超阈值刺激导致在治疗之后3小时TNF的显著抑制。因此,影响是持久的,并且来自单个脉冲的3小时处的影响与由多达3000个脉冲产生的影响相当。
进行第二类似实验,以检查单个超阈值脉冲对胆碱能抗炎通路(CAP)的持久影响。小鼠(雄性,BALB/c)被麻醉,并且袖口电极(0.3mm ID,0.5mm电极间距离;微探针,Gaithersburg,MD)被置于左颈动脉鞘(包含颈迷走神经)周围且通过缝合来固定。超阈值脉冲(750μA,200μS,10Hz)以各种数目(0,1,600)施加。后来,电极被移除并且关闭钉上的伤口。小鼠恢复持续24小时,并且然后使用LPS(5mg/kg;IP)来进行挑战;这些小鼠在LPS之后90分钟牺牲,并且血清TNF通过ELISA测得,以测量对炎症性细胞因子的影响。如图3上所示,单个超阈值刺激导致在治疗之后24小时处TNF的显著抑制,其与由600个脉冲产生的影响相当。
图4将以上所描述的两个实验的结果的选择的部分组合,以显示NCAP的单个脉冲刺激以与600个脉冲相同的效力影响刺激后3小时和24小时的可由LPS诱导的TNF的抑制。
在另一示例中,进行实验以确定在针对IBD/克罗恩病的大鼠模型中的损伤区域的单个脉冲抑制的效力。大鼠被麻醉,并且被给予对左颈迷走神经的虚假刺激或者单个超阈值刺激(在750μA、200μS的脉冲宽度、10Hz处的1个脉冲)。IBD通过吲哚美辛(5%碳酸氢钠中的10mg/kg(5mg/mL))的SC注射在刺激后30分钟被诱导。通过使用异氟烷麻醉大鼠并且使用依文思蓝(1%的0.3ml)的四尾部注射来在吲哚美辛注射之后23.5小时完全玷污损伤。大鼠在疾病诱导后24小时经由CO2窒息而牺牲,并且整夜在2%的福尔马林中收割、清洗和固定小肠。对已固定的肠道进行拍照并对照片进行数字化,并且损伤通过盲打分器(blinded scorer)来量化。如图5中图示的,单个超阈值刺激(750μA、200μS的脉冲宽度、10Hz)导致损伤的深刻减少。
考虑到图6中所示的数据,这些结果甚至更为重要,图6图示了在克罗恩病的大鼠模型中迷走神经刺激的“存储器效应”。大鼠被麻醉,并且被给予对左颈迷走神经(1mA、200μS的脉冲宽度、10Hz、60s)的虚假刺激或实际刺激。IBD/克罗恩病通过吲哚美辛(5%碳酸氢钠中的10mg/kg(5mg/mL))的SC注射在刺激之后不同的时间点(见图6)被诱导。通过使用异氟烷麻醉大鼠并且使用依文思蓝(1%的0.3ml)的四尾部注射来在疾病诱导之后23.5小时完全玷污损伤。大鼠在疾病诱导后24小时经由CO2窒息而牺牲,并且整夜在2%的福尔马林中收割、清洗和固定小肠。对已固定的肠道进行拍照并对照片进行数字化,并且损伤通过盲打分器来量化。在该示例中,迷走神经刺激的短暂时期可以导致在减少另外由吲哚美辛的应用所诱导的肠道损伤方面惊人地持久的影响(例如高达48小时)。该数据强烈建议可以极不频繁地提供刺激,具有长的(例如>48小时)、没有所施加的刺激的“寂静”周期。用于治疗IBD的这样的极低占空比刺激可以在可植入系统中尤其有帮助,允许极长的电池寿命,同时具有出乎意料地稳健的疗效。
尽管以上提供的示例描述了用于在大鼠模型中治疗炎症性疾病的方法、系统和设备,但是本文所描述的所有方法、系统和设备可以用于和/或适用于在其他哺乳动物(例如人类)中使用。例如,一种用于使用单个超阈值脉冲和/或格外低占空比刺激方案治疗人类的炎症性疾病的系统和方法可以包括电极(诸如袖口电极),该电极被配置为围绕迷走神经植入并且将电刺激传递到患者的迷走神经。该系统可以进一步包括处理器、用于存储指令的存储器、和/或控制器,该控制器可以包括编程以将包括单个超阈值脉冲方案在内的低占空比刺激方案经由袖口电极传递到迷走神经。可以提供电池来为系统提供功率,并且因为低占空比刺激方案消耗很少的能量,所以电池寿命可以大大延长,允许在电池需要更换或再充电之前系统被完整地植入患者体内很长一段时间。对于植入系统,这提供大的益处,因为其可以减少外科手术的频率,该外科手术可以被要求更换电池。
在该系统中使用的刺激参数可以与以上公开的参数相同或相似。例如,脉冲振幅可以小于大约5、4、3或2mA。另外,低占空比刺激方案可以在介于大约4到48小时之间或者至少4、12、24或48小时的关断时间之间传递单个超阈值脉冲。在一些实施例中,脉冲宽度可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
一般而言,这些结果暗示,迷走神经的甚至单个短暂超阈值刺激的应用可以可能通过抑制炎症性细胞因子(诸如TNF)而导致炎症影响的大量减少。这些结果既令人惊讶(考虑到刺激持续长得多的时间的现有技术趋势),又对于设计今后的设备和方法是重要的。尤其是,迷走神经(或炎症性反应的其他部分)的刺激可以被配置为施加极低占空比刺激。如简要地提到的,这将考虑到更小、更轻和更有效率的可植入刺激系统。
如本文所描述的可以被治疗的各种类型的炎症性疾病包括各种疾病状态,包括诸如枯草热、动脉粥样硬化、关节炎(类风湿、滑囊炎、痛风性关节炎、风湿性多肌痛等)、哮喘、自身免疫疾病、慢性炎症、慢性前列腺炎、肾小球肾炎、肾炎、炎症性肠病、盆腔炎性疾病、再灌注损伤、移植排斥、血管炎、心肌炎、结肠炎等疾病。
可以使用本发明治疗的炎症性疾病的非限制性示例包括:阑尾炎、消化性溃疡、胃溃疡、十二指肠溃疡、腹膜炎、胰腺炎、溃疡性结肠炎、伪膜性肠炎、急性结肠炎、缺血性结肠炎、憩室炎、会厌炎、失弛缓症、胆管炎、胆囊炎、肝炎、克罗恩病、肠炎、惠普尔病、过敏、过敏性休克、免疫复合物病、器官缺血、再灌注损伤、器官坏死、枯草热、脓毒症、败血症、内毒素性休克、恶病质、高热、嗜酸性肉芽肿、肉芽肿病、结节病、脓毒性流产、附睾炎、阴道炎、前列腺炎、尿道炎、支气管炎、肺气肿、鼻炎、肺炎、火山矽肺病、牙槽炎、支气管炎、咽炎、胸膜炎、鼻窦炎、流感、呼吸道合胞病毒感染、HIV感染、乙型肝炎病毒感染、丙型肝炎病毒感染、疱疹病毒感染播散菌血症、登革热、念珠菌病、疟疾、丝虫病、变形虫病、包虫囊肿、烧伤、皮炎、皮肌炎、晒伤、荨麻疹、疣、风团、血管炎、脉管炎、心内膜炎、动脉炎、动脉粥样硬化、血栓性静脉炎、心包炎、心肌炎、心肌缺血、结节性动脉周炎、风湿热、阿尔茨海默氏病、腹部疾病、充血性心脏衰竭、成人呼吸窘迫综合征、脑膜炎、脑炎、多发性硬化、脑梗塞、脑栓塞、格林-巴利综合征、神经炎、神经痛、脊髓损伤、瘫痪、葡萄膜炎、关节炎、关节痛、骨髓炎、筋膜炎、佩吉特氏病、痛风、牙周病、类风湿性关节炎、滑膜炎、重症肌无力、甲状腺炎、系统性红斑狼疮、古德帕斯彻氏综合征、白塞氏综合征、同种异体移植物排斥、移植物抗宿主病、一型糖尿病、二型糖尿病、强直性脊柱炎、伯杰氏病、赖特综合征、何杰金氏病、肠梗阻、高血压、肠易激综合征、心肌梗死、失眠、焦虑以及支架血栓。
这些疾病中的任何一种疾病(例如炎症性疾病)可以例如通过在迷走神经周围植入袖口电极并且使用如本文所述的用于治疗的格外低占空比刺激方案来治疗。用于存储指令和/或编程的处理器以及存储器可以用来控制刺激方案。在该系统和方法中使用的刺激参数可以与以上公开的参数相同或相似。例如,单个超阈值脉冲的脉冲振幅可以小于大约5、4、3或2mA。另外,低占空比刺激方案可以在介于大约4到48小时之间或者至少4、12、24或48小时的关断时间之间传递单个超阈值脉冲。这些方法中的任何一种方法可以包括确定治疗功效的步骤。例如,这些方法中的任何一种方法可以包括在治疗前和/或期间监视患者的步骤。例如,在治疗炎症性疾病中,可以监视用于炎症的生物标志物,例如细胞因子或其他标志物。在一些变化形式中,监视患者可以包括可视化地评估患者(例如,针对肿胀、体温等)。在一些变化形式中,本文所描述的系统可以包括用于监视患者和/或使用该系统的治疗效果的传感器和/或数据处理子系统。
尽管以上示例和描述主要集中在炎症性疾病上,但是在某一实施例中,本文所描述的系统、设备和方法可以用于治疗非炎症性病症或疾病。例如,本文所描述的系统、设备和方法可以用来通过迷走神经的格外低占空比刺激激活、调节和/或调整去乙酰化酶(sirtuin)的水平。通过迷走神经刺激的去乙酰化酶的调整还在2011年12月27日提交并且题为“MODULATION OF SIRTUINS BY VAGUS NERVESTIMULATION”的美国申请13/338,185中进行了讨论,该申请出于所有目的通过引用全文结合于此。如上,袖口电极可以围绕迷走神经植入,并且用于存储指令和/或编程的处理器和存储器可以用来控制刺激方案。在该系统和方法中使用的刺激参数可以与以上公开的参数相同或相似。例如,单个超阈值脉冲的脉冲振幅可以小于大约5、4、3或2mA。另外,低占空比刺激方案可以在介于大约4到48小时之间或者至少4、12、24或48小时的关断时间之间传递单个超阈值脉冲。在一些实施例中,脉冲宽度可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
如上所述,在一些实施例中,系统、设备和/或方法包括监测刺激对正在治疗的疾病的影响。例如,炎症指示器或疾病指示器或其他指示器可以被监测以评价治疗方案的功效,允许基于该评价调节刺激方案。可以基于该评价调整本文所述参数中的任何一个参数。例如,可以增加或减少脉冲振幅和/或关断时间以优化疗效。可以被监测的指示器的示例包括TNF水平、损伤尺寸、炎症的程度或水平,细胞因子水平、疼痛水平、去乙酰化酶水平,等等。
本文公开的设备和方法的变化和修改对于本领域技术人员而言将很容易是显而易见的。同样地,应当理解的是,前述详细描述和附图是出于清晰和理解的目的而做出,并且并非旨在限制本发明的范围,本发明的范围由附于其的权利要求来限定。在本文所述任何一个实施例中所描述的任何特征可以与其它实施例中的任何实施例的任何其他特征组合而不论是否是优选的。
理解的是,本文所述示例和实施例仅仅是出于说明的目的,并且根据其的各种修改或改变将被建议给本领域技术人员,并且将被包括在本申请的精神和权限以及所附权利要求的范围以内。本文所引用的所有出版物、专利和专利申请出于所有目的通过引用被结合于此。

Claims (20)

1.一种用于治疗患者的慢性炎症的系统,所述系统包括:
可植入微刺激器,被配置为向迷走神经施加低占空比刺激,其中所述低占空比刺激每4小时仅提供单个超阈值脉冲;以及
控制器,被配置为设置用于所述微刺激器的剂量,其中所述剂量包括被至少4小时的关断周期跟随的所述单个超阈值脉冲。
2.根据权利要求1所述的系统,其中所述关断周期是至少24小时。
3.根据权利要求1所述的系统,其中所述关断周期是至少48小时。
4.根据权利要求1所述的系统,其中所述单个超阈值脉冲具有小于5mA的脉冲振幅。
5.根据权利要求1所述的系统,其中所述单个超阈值脉冲具有小于3mA的脉冲振幅。
6.根据权利要求1所述的系统,其中所述单个超阈值脉冲具有小于2mA的脉冲振幅。
7.根据权利要求1所述的系统,其中所述单个超阈值脉冲是双相的。
8.根据权利要求1所述的系统,其中所述慢性炎症是肠道炎症。
9.根据权利要求1所述的系统,其中所述慢性炎症是炎症性肠病。
10.根据权利要求1所述的系统,其中所述慢性炎症是克罗恩病。
11.一种治疗患者的慢性炎症的方法,所述方法包括:
植入微刺激器;以及
向迷走神经仅施加来自所述微刺激器的单个超阈值刺激脉冲,所述单个超阈值刺激脉冲被至少4小时的关断时间跟随。
12.根据权利要求11所述的方法,其中所述关断时间是至少24小时。
13.根据权利要求11所述的方法,其中所述关断时间是至少48小时。
14.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲具有小于5mA的脉冲振幅。
15.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲具有小于3mA的脉冲振幅。
16.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲具有小于2mA的脉冲振幅。
17.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲是双相的。
18.根据权利要求11所述的方法,其中所述慢性炎症是肠道炎症。
19.根据权利要求11所述的方法,其中所述慢性炎症是炎症性肠病。
20.根据权利要求11所述的方法,其中所述慢性炎症是克罗恩病。
CN201280031279.9A 2011-05-09 2012-05-09 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 Active CN103619405B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161484112P 2011-05-09 2011-05-09
US61/484,112 2011-05-09
PCT/US2012/037142 WO2012154865A2 (en) 2011-05-09 2012-05-09 Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation

Publications (2)

Publication Number Publication Date
CN103619405A true CN103619405A (zh) 2014-03-05
CN103619405B CN103619405B (zh) 2015-11-25

Family

ID=47139976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280031279.9A Active CN103619405B (zh) 2011-05-09 2012-05-09 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活

Country Status (4)

Country Link
US (1) US8788034B2 (zh)
EP (1) EP2707094B1 (zh)
CN (1) CN103619405B (zh)
WO (1) WO2012154865A2 (zh)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108290041A (zh) * 2015-04-24 2018-07-17 伽尔伐尼生物电子有限公司 神经调节设备
CN109069824A (zh) * 2016-02-02 2018-12-21 阿莱瓦神经治疗股份有限公司 使用深部脑刺激治疗自身免疫疾病
US11266830B2 (en) 2018-03-02 2022-03-08 Aleva Neurotherapeutics Neurostimulation device
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US11730953B2 (en) 2014-08-27 2023-08-22 Aleva Neurotherapeutics Deep brain stimulation lead
US11766560B2 (en) 2010-04-01 2023-09-26 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
EP1734941A2 (en) 2004-03-25 2006-12-27 The Feinstein Institute for Medical Research Neural tourniquet
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US8233976B2 (en) 2007-12-05 2012-07-31 The Invention Science Fund I, Llc System for transdermal chemical modulation of neural activity
US8160695B2 (en) * 2007-12-05 2012-04-17 The Invention Science Fund I, Llc System for chemical modulation of neural activity
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
KR101719824B1 (ko) 2008-05-09 2017-04-04 호라이라 인코포레이티드 기관지나무 치료용 시스템, 어셈블리 및 방법
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en) * 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
WO2010144578A2 (en) 2009-06-09 2010-12-16 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
CN104856757B (zh) 2009-10-27 2017-06-23 赫莱拉公司 具有可冷却的能量发射组件的递送装置
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US20150241447A1 (en) * 2009-11-17 2015-08-27 Ralph J. ZITNIK Vagus nerve stimulation screening test
WO2011079309A2 (en) 2009-12-23 2011-06-30 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US20220072309A9 (en) * 2011-05-09 2022-03-10 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9782584B2 (en) 2014-06-13 2017-10-10 Nervana, LLC Transcutaneous electrostimulator and methods for electric stimulation
US10130809B2 (en) 2014-06-13 2018-11-20 Nervana, LLC Transcutaneous electrostimulator and methods for electric stimulation
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
CN108882885A (zh) * 2016-01-20 2018-11-23 赛博恩特医疗器械公司 迷走神经刺激的控制
EP3405255A4 (en) 2016-01-20 2019-10-16 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION RECHARGE SYSTEMS
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
PL3481285T3 (pl) 2016-07-07 2021-03-08 The Regents Of The University Of California Implanty wykorzystujące fale ultradźwiękowe do stymulacji tkanek
US10335396B2 (en) 2016-10-27 2019-07-02 Patrick M. Nemechek Methods of reversing autonomic nervous system damage
WO2019036470A1 (en) 2017-08-14 2019-02-21 Setpoint Medical Corporation TESTING TEST FOR STIMULATION OF NERVE WAVE
EP3470111A1 (en) 2017-10-13 2019-04-17 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
BR112020021383A2 (pt) 2018-04-19 2021-01-26 Iota Biosciences, Inc. implantes que usam comunicação ultrassônica para detecção e estimulação neural
CN112351812A (zh) 2018-04-19 2021-02-09 艾奧塔生物科技公司 用于调节脾神经活动的使用超声通信的植入物
KR20210053915A (ko) 2018-08-29 2021-05-12 아이오타 바이오사이언시즈 인코퍼레이티드 이식 가능한 폐회로 뉴로모듈레이션 장치, 시스템 및 사용 방법
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2020210786A1 (en) 2019-04-12 2020-10-15 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
US11938324B2 (en) 2020-05-21 2024-03-26 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
US11123560B1 (en) 2020-06-08 2021-09-21 Patrick M. Nemechek Methods of treating covid-19 induced cytokine storm

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208266A1 (en) * 2003-07-18 2008-08-28 The Johns Hopkins University System and Method for Treating Nausea and Vomiting by Vagus Nerve Stimulation
CN101528303A (zh) * 2006-08-29 2009-09-09 心脏起搏器股份公司 用于神经刺激的系统
WO2010005482A1 (en) * 2008-07-08 2010-01-14 Cardiac Pacemakers, Inc. Systems for delivering vagal nerve stimulation
WO2010067360A2 (en) * 2008-12-09 2010-06-17 Nephera Ltd. Stimulation of the urinary system
CN101868280A (zh) * 2007-09-25 2010-10-20 心脏起搏器股份公司 用于心脏病症的神经刺激系统
US20110190849A1 (en) * 2009-12-23 2011-08-04 Faltys Michael A Neural stimulation devices and systems for treatment of chronic inflammation

Family Cites Families (450)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2164121A (en) 1938-05-04 1939-06-27 Pescador Hector Electric hearing apparatus for the deaf
US3363623A (en) 1965-07-28 1968-01-16 Charles F. Atwell Hand-held double-acting nerve reflex massager
FR2315274A1 (fr) 1975-06-27 1977-01-21 Parcor Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications
US4073296A (en) 1976-01-02 1978-02-14 Mccall Francis J Apparatus for acupressure treatment
US4098277A (en) 1977-01-28 1978-07-04 Sherwin Mendell Fitted, integrally molded device for stimulating auricular acupuncture points and method of making the device
US4305402A (en) 1979-06-29 1981-12-15 Katims Jefferson J Method for transcutaneous electrical stimulation
US4503863A (en) 1979-06-29 1985-03-12 Katims Jefferson J Method and apparatus for transcutaneous electrical stimulation
US5025807A (en) 1983-09-14 1991-06-25 Jacob Zabara Neurocybernetic prosthesis
US4867164A (en) 1983-09-14 1989-09-19 Jacob Zabara Neurocybernetic prosthesis
US4702254A (en) 1983-09-14 1987-10-27 Jacob Zabara Neurocybernetic prosthesis
US4590946A (en) 1984-06-14 1986-05-27 Biomed Concepts, Inc. Surgically implantable electrode for nerve bundles
US4573481A (en) 1984-06-25 1986-03-04 Huntington Institute Of Applied Research Implantable electrode array
US4649936A (en) 1984-10-11 1987-03-17 Case Western Reserve University Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking
US4632095A (en) 1984-11-05 1986-12-30 Tamiko Inc. Pressure-point attachment for use with electrical hand-held massagers
US4930516B1 (en) 1985-11-13 1998-08-04 Laser Diagnostic Instr Inc Method for detecting cancerous tissue using visible native luminescence
US4929734A (en) 1987-03-31 1990-05-29 Warner-Lambert Company Tetrahydropyridine oxime compounds
US4935234A (en) 1987-06-11 1990-06-19 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US4840793A (en) 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5019648A (en) 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
DE3736664A1 (de) 1987-10-29 1989-05-11 Boehringer Ingelheim Kg Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
US5038781A (en) 1988-01-21 1991-08-13 Hassan Hamedi Multi-electrode neurological stimulation apparatus
US5049659A (en) 1988-02-09 1991-09-17 Dana Farber Cancer Institute Proteins which induce immunological effector cell activation and chemattraction
US4920979A (en) 1988-10-12 1990-05-01 Huntington Medical Research Institute Bidirectional helical electrode for nerve stimulation
US4991578A (en) 1989-04-04 1991-02-12 Siemens-Pacesetter, Inc. Method and system for implanting self-anchoring epicardial defibrillation electrodes
US5106853A (en) 1989-05-15 1992-04-21 Merck Sharp & Dohme, Ltd. Oxadiazole and its salts, their use in treating dementia
US4979511A (en) 1989-11-03 1990-12-25 Cyberonics, Inc. Strain relief tether for implantable electrode
US5235980A (en) 1989-11-13 1993-08-17 Cyberonics, Inc. Implanted apparatus disabling switching regulator operation to allow radio frequency signal reception
US5154172A (en) 1989-11-13 1992-10-13 Cyberonics, Inc. Constant current sources with programmable voltage source
US5179950A (en) 1989-11-13 1993-01-19 Cyberonics, Inc. Implanted apparatus having micro processor controlled current and voltage sources with reduced voltage levels when not providing stimulation
US5186170A (en) 1989-11-13 1993-02-16 Cyberonics, Inc. Simultaneous radio frequency and magnetic field microprocessor reset circuit
US5503978A (en) 1990-06-11 1996-04-02 University Research Corporation Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US6168778B1 (en) 1990-06-11 2001-01-02 Nexstar Pharmaceuticals, Inc. Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5726017A (en) 1990-06-11 1998-03-10 Nexstar Pharmaceuticals, Inc. High affinity HIV-1 gag nucleic acid ligands
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5712375A (en) 1990-06-11 1998-01-27 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US6083696A (en) 1990-06-11 2000-07-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands exponential enrichment: blended selex
US5472841A (en) 1990-06-11 1995-12-05 Nexstar Pharmaceuticals, Inc. Methods for identifying nucleic acid ligands of human neutrophil elastase
US6140490A (en) 1996-02-01 2000-10-31 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of complement system proteins
US5654151A (en) 1990-06-11 1997-08-05 Nexstar Pharmaceuticals, Inc. High affinity HIV Nucleocapsid nucleic acid ligands
US6147204A (en) 1990-06-11 2000-11-14 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
ATE318832T1 (de) 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
US6127119A (en) 1990-06-11 2000-10-03 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US6124449A (en) 1990-06-11 2000-09-26 Nexstar Pharmaceuticals, Inc. High affinity TGFβ nucleic acid ligands and inhibitors
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US5073560A (en) 1990-07-20 1991-12-17 Fisons Corporation Spiro-isoxazolidine derivatives as cholinergic agents
US5111815A (en) 1990-10-15 1992-05-12 Cardiac Pacemakers, Inc. Method and apparatus for cardioverter/pacer utilizing neurosensing
US5188104A (en) 1991-02-01 1993-02-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5263480A (en) 1991-02-01 1993-11-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5269303A (en) 1991-02-22 1993-12-14 Cyberonics, Inc. Treatment of dementia by nerve stimulation
US5251634A (en) 1991-05-03 1993-10-12 Cyberonics, Inc. Helical nerve electrode
US5335657A (en) 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
US5215086A (en) 1991-05-03 1993-06-01 Cyberonics, Inc. Therapeutic treatment of migraine symptoms by stimulation
US5299569A (en) 1991-05-03 1994-04-05 Cyberonics, Inc. Treatment of neuropsychiatric disorders by nerve stimulation
US6028186A (en) 1991-06-10 2000-02-22 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of cytokines
US5205285A (en) 1991-06-14 1993-04-27 Cyberonics, Inc. Voice suppression of vagal stimulation
AU2339792A (en) 1991-07-22 1993-02-23 Cyberonics, Inc. Treatment of respiratory disorders by nerve stimulation
US5222494A (en) 1991-07-31 1993-06-29 Cyberonics, Inc. Implantable tissue stimulator output stabilization system
US5231988A (en) 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5582981A (en) 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5175166A (en) 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
US5215089A (en) 1991-10-21 1993-06-01 Cyberonics, Inc. Electrode assembly for nerve stimulation
US5304206A (en) 1991-11-18 1994-04-19 Cyberonics, Inc. Activation techniques for implantable medical device
US5237991A (en) 1991-11-19 1993-08-24 Cyberonics, Inc. Implantable medical device with dummy load for pre-implant testing in sterile package and facilitating electrical lead connection
US5203326A (en) 1991-12-18 1993-04-20 Telectronics Pacing Systems, Inc. Antiarrhythmia pacer using antiarrhythmia pacing and autonomic nerve stimulation therapy
US5330507A (en) 1992-04-24 1994-07-19 Medtronic, Inc. Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias
US5330515A (en) 1992-06-17 1994-07-19 Cyberonics, Inc. Treatment of pain by vagal afferent stimulation
US5977144A (en) 1992-08-31 1999-11-02 University Of Florida Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
ATE230989T1 (de) 1992-08-31 2003-02-15 Univ Florida Anabasein derivate zur behandlung von degenerativen erkrankungen des nervensystems
JPH08506254A (ja) 1993-02-10 1996-07-09 シーメンス アクチエンゲゼルシヤフト 鎮痛治療のための、および/または植物神経系に作用を与える装置および方法
US5344438A (en) 1993-04-16 1994-09-06 Medtronic, Inc. Cuff electrode
AU698101B2 (en) 1993-06-01 1998-10-22 Cortex Pharmaceuticals, Inc. Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
US5594106A (en) 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US5599984A (en) 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
JP3269125B2 (ja) 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
ES2157326T3 (es) 1994-04-22 2001-08-16 Sanquin Bloedvoorziening Sistema para el tratamiento de anomalias en la cascada de coagulacion sanguinea.
US5458625A (en) 1994-05-04 1995-10-17 Kendall; Donald E. Transcutaneous nerve stimulation device and method for using same
US6017891A (en) 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
US6405732B1 (en) 1994-06-24 2002-06-18 Curon Medical, Inc. Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors
PL183933B1 (pl) 1994-08-24 2002-08-30 Astra Ab Związki spiroazabicyklo, sposób wytwarzania związku spiroazabicyklo i kompozycja farmaceutyczna
US5531778A (en) 1994-09-20 1996-07-02 Cyberonics, Inc. Circumneural electrode assembly
US5540734A (en) 1994-09-28 1996-07-30 Zabara; Jacob Cranial nerve stimulation treatments using neurocybernetic prosthesis
US5571150A (en) 1994-12-19 1996-11-05 Cyberonics, Inc. Treatment of patients in coma by nerve stimulation
US5487756A (en) 1994-12-23 1996-01-30 Simon Fraser University Implantable cuff having improved closure
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US5707400A (en) 1995-09-19 1998-01-13 Cyberonics, Inc. Treating refractory hypertension by nerve stimulation
US5700282A (en) 1995-10-13 1997-12-23 Zabara; Jacob Heart rhythm stabilization using a neurocybernetic prosthesis
WO1997014473A1 (en) 1995-10-18 1997-04-24 Novartis Ag Thermopile powered transdermal drug delivery device
US5611350A (en) 1996-02-08 1997-03-18 John; Michael S. Method and apparatus for facilitating recovery of patients in deep coma
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6051017A (en) 1996-02-20 2000-04-18 Advanced Bionics Corporation Implantable microstimulator and systems employing the same
US5913876A (en) 1996-02-20 1999-06-22 Cardiothoracic Systems, Inc. Method and apparatus for using vagus nerve stimulation in surgery
US5651378A (en) 1996-02-20 1997-07-29 Cardiothoracic Systems, Inc. Method of using vagal nerve stimulation in surgery
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
DE59712322D1 (de) 1996-03-20 2005-06-30 Baxter Ag Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
US5618818A (en) 1996-03-20 1997-04-08 The University Of Toledo Muscarinic agonist compounds
US5964794A (en) 1996-03-21 1999-10-12 Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin Implantable stimulation electrode
US5690681A (en) 1996-03-29 1997-11-25 Purdue Research Foundation Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US5726179A (en) 1996-04-01 1998-03-10 The University Of Toledo Muscarinic agonists
US6166048A (en) 1999-04-20 2000-12-26 Targacept, Inc. Pharmaceutical compositions for inhibition of cytokine production and secretion
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
USRE38705E1 (en) 1996-04-30 2005-02-22 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US6628987B1 (en) 2000-09-26 2003-09-30 Medtronic, Inc. Method and system for sensing cardiac contractions during vagal stimulation-induced cardiopalegia
US6904318B2 (en) 2000-09-26 2005-06-07 Medtronic, Inc. Method and system for monitoring and controlling systemic and pulmonary circulation during a medical procedure
US20040199209A1 (en) 2003-04-07 2004-10-07 Hill Michael R.S. Method and system for delivery of vasoactive drugs to the heart prior to and during a medical procedure
US6532388B1 (en) 1996-04-30 2003-03-11 Medtronic, Inc. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US6735471B2 (en) 1996-04-30 2004-05-11 Medtronic, Inc. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US5853005A (en) 1996-05-02 1998-12-29 The United States Of America As Represented By The Secretary Of The Army Acoustic monitoring system
WO1997045160A1 (en) 1996-05-31 1997-12-04 Southern Illinois University Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
US5792210A (en) 1996-06-10 1998-08-11 Environmental Behavior Modification Inc. Electrical tongue stimulator and method for addiction treatment
JPH1094613A (ja) 1996-08-02 1998-04-14 Mieko Sato 食欲調整用具
US5718912A (en) 1996-10-28 1998-02-17 Merck & Co., Inc. Muscarine agonists
ES2339306T3 (es) 1996-11-15 2010-05-18 Cytokine Pharmasciences, Inc. Guanilhidrazonas utiles en el tratamiento de las enfermedades asociadas con la activacion de las celulas t.
US6164284A (en) 1997-02-26 2000-12-26 Schulman; Joseph H. System of implantable devices for monitoring and/or affecting body parameters
US5788656A (en) 1997-02-28 1998-08-04 Mino; Alfonso Di Electronic stimulation system for treating tinnitus disorders
US5919216A (en) 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
US5824027A (en) 1997-08-14 1998-10-20 Simon Fraser University Nerve cuff having one or more isolated chambers
US6479523B1 (en) 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
US6011005A (en) 1997-09-18 2000-01-04 The Picower Institute For Medical Research Prevention of pregnancy miscarriages
US6141590A (en) 1997-09-25 2000-10-31 Medtronic, Inc. System and method for respiration-modulated pacing
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6018682A (en) 1998-04-30 2000-01-25 Medtronic, Inc. Implantable seizure warning system
US5928272A (en) 1998-05-02 1999-07-27 Cyberonics, Inc. Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity
US6002964A (en) 1998-07-15 1999-12-14 Feler; Claudio A. Epidural nerve root stimulation
US7599736B2 (en) 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US6208902B1 (en) 1998-10-26 2001-03-27 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy for pain syndromes utilizing an implantable lead and an external stimulator
US6615081B1 (en) 1998-10-26 2003-09-02 Birinder R. Boveja Apparatus and method for adjunct (add-on) treatment of diabetes by neuromodulation with an external stimulator
US7076307B2 (en) 2002-05-09 2006-07-11 Boveja Birinder R Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders
US6611715B1 (en) 1998-10-26 2003-08-26 Birinder R. Boveja Apparatus and method for neuromodulation therapy for obesity and compulsive eating disorders using an implantable lead-receiver and an external stimulator
US6505074B2 (en) 1998-10-26 2003-01-07 Birinder R. Boveja Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator
US6564102B1 (en) 1998-10-26 2003-05-13 Birinder R. Boveja Apparatus and method for adjunct (add-on) treatment of coma and traumatic brain injury with neuromodulation using an external stimulator
US6205359B1 (en) 1998-10-26 2001-03-20 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6356788B2 (en) 1998-10-26 2002-03-12 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6668191B1 (en) 1998-10-26 2003-12-23 Birinder R. Boveja Apparatus and method for electrical stimulation adjunct (add-on) therapy of atrial fibrillation, inappropriate sinus tachycardia, and refractory hypertension with an external stimulator
US20030212440A1 (en) 2002-05-09 2003-11-13 Boveja Birinder R. Method and system for modulating the vagus nerve (10th cranial nerve) using modulated electrical pulses with an inductively coupled stimulation system
US6366814B1 (en) 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US6269270B1 (en) 1998-10-26 2001-07-31 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator
US20050137644A1 (en) 1998-10-26 2005-06-23 Boveja Birinder R. Method and system for vagal blocking and/or vagal stimulation to provide therapy for obesity and other gastrointestinal disorders
US5994330A (en) 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
FR2786770B1 (fr) 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
US6376675B2 (en) 1999-01-22 2002-04-23 The University Of Toledo Muscarinic receptor agonists
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US6341236B1 (en) 1999-04-30 2002-01-22 Ivan Osorio Vagal nerve stimulation techniques for treatment of epileptic seizures
US6233488B1 (en) 1999-06-25 2001-05-15 Carl A. Hess Spinal cord stimulation as a treatment for addiction to nicotine and other chemical substances
EP1198271A4 (en) 1999-06-25 2009-01-21 Univ Emory DEVICES AND METHODS FOR STIMULATING THE VAGUSNERVS
US6587719B1 (en) 1999-07-01 2003-07-01 Cyberonics, Inc. Treatment of obesity by bilateral vagus nerve stimulation
US6804558B2 (en) 1999-07-07 2004-10-12 Medtronic, Inc. System and method of communicating between an implantable medical device and a remote computer system or health care provider
US6210321B1 (en) 1999-07-29 2001-04-03 Adm Tronics Unlimited, Inc. Electronic stimulation system for treating tinnitus disorders
US6171795B1 (en) 1999-07-29 2001-01-09 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to CD40ligand
US6304775B1 (en) 1999-09-22 2001-10-16 Leonidas D. Iasemidis Seizure warning and prediction
US6636767B1 (en) 1999-09-29 2003-10-21 Restore Medical, Inc. Implanatable stimulation device for snoring treatment
US6473644B1 (en) 1999-10-13 2002-10-29 Cyberonics, Inc. Method to enhance cardiac capillary growth in heart failure patients
US20020026141A1 (en) 1999-11-04 2002-02-28 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
FR2803186B1 (fr) 2000-01-05 2002-08-09 Guy Charvin Procede et dispositif de recueil de potentiels evoques auditif
US6447443B1 (en) 2001-01-13 2002-09-10 Medtronic, Inc. Method for organ positioning and stabilization
US6356787B1 (en) 2000-02-24 2002-03-12 Electro Core Techniques, Llc Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain
US20060085046A1 (en) 2000-01-20 2006-04-20 Ali Rezai Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system
US6885888B2 (en) 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
JP2003530169A (ja) 2000-04-11 2003-10-14 ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム 胃腸管の電気刺激
US6826428B1 (en) 2000-04-11 2004-11-30 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US6610713B2 (en) 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US6511500B1 (en) 2000-06-06 2003-01-28 Marc Mounir Rahme Use of autonomic nervous system neurotransmitters inhibition and atrial parasympathetic fibers ablation for the treatment of atrial arrhythmias and to preserve drug effects
AU2001282873A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
WO2002026140A1 (en) 2000-09-26 2002-04-04 Medtronic, Inc. Medical method and system for directing blood flow
US20020077675A1 (en) 2000-09-26 2002-06-20 Transneuronix, Inc. Minimally invasive surgery placement of stimulation leads in mediastinal structures
EP1326678A2 (en) 2000-10-11 2003-07-16 Ronald R. Riso Nerve cuff electrode
US7011638B2 (en) 2000-11-14 2006-03-14 Science Medicus, Inc. Device and procedure to treat cardiac atrial arrhythmias
US6832114B1 (en) 2000-11-21 2004-12-14 Advanced Bionics Corporation Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US6633779B1 (en) 2000-11-27 2003-10-14 Science Medicus, Inc. Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms
US6884807B2 (en) 2000-12-01 2005-04-26 Neurosearch, A/S 3-substituted quinuclidines and their use as nicotinic agonists
US20020086871A1 (en) 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
US6609025B2 (en) 2001-01-02 2003-08-19 Cyberonics, Inc. Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation
US7519421B2 (en) 2001-01-16 2009-04-14 Kenergy, Inc. Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation
WO2002057275A1 (en) 2001-01-17 2002-07-25 University Of Kentucky Research Foundation Boron-containing nicotine analogs for use in the treatment of cns pathologies
US6735475B1 (en) 2001-01-30 2004-05-11 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
JP2004524125A (ja) 2001-04-05 2004-08-12 メド−エル・エレクトロメディツィニシェ・ゲラーテ・ゲーエムベーハー 両側声帯自律麻痺のためのペースメーカー
US7369897B2 (en) 2001-04-19 2008-05-06 Neuro And Cardiac Technologies, Llc Method and system of remotely controlling electrical pulses provided to nerve tissue(s) by an implanted stimulator system for neuromodulation therapies
US20050240229A1 (en) 2001-04-26 2005-10-27 Whitehurst Tood K Methods and systems for stimulation as a therapy for erectile dysfunction
US6684105B2 (en) 2001-08-31 2004-01-27 Biocontrol Medical, Ltd. Treatment of disorders by unidirectional nerve stimulation
US6928320B2 (en) 2001-05-17 2005-08-09 Medtronic, Inc. Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US6947782B2 (en) 2001-06-18 2005-09-20 Alfred E. Mann Foundation For Scientific Research Miniature implantable connectors
US7054692B1 (en) 2001-06-22 2006-05-30 Advanced Bionics Corporation Fixation device for implantable microdevices
US20060167498A1 (en) 2001-07-23 2006-07-27 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US6622038B2 (en) 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of movement disorders by near-diaphragmatic nerve stimulation
US6622047B2 (en) 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation
US6622041B2 (en) 2001-08-21 2003-09-16 Cyberonics, Inc. Treatment of congestive heart failure and autonomic cardiovascular drive disorders
US6600956B2 (en) 2001-08-21 2003-07-29 Cyberonics, Inc. Circumneural electrode assembly
US6760626B1 (en) 2001-08-29 2004-07-06 Birinder R. Boveja Apparatus and method for treatment of neurological and neuropsychiatric disorders using programmerless implantable pulse generator system
US7054686B2 (en) 2001-08-30 2006-05-30 Biophan Technologies, Inc. Pulsewidth electrical stimulation
US7778703B2 (en) 2001-08-31 2010-08-17 Bio Control Medical (B.C.M.) Ltd. Selective nerve fiber stimulation for treating heart conditions
US7734355B2 (en) 2001-08-31 2010-06-08 Bio Control Medical (B.C.M.) Ltd. Treatment of disorders by unidirectional nerve stimulation
US8615294B2 (en) 2008-08-13 2013-12-24 Bio Control Medical (B.C.M.) Ltd. Electrode devices for nerve stimulation and cardiac sensing
US7974693B2 (en) 2001-08-31 2011-07-05 Bio Control Medical (B.C.M.) Ltd. Techniques for applying, configuring, and coordinating nerve fiber stimulation
US7885709B2 (en) 2001-08-31 2011-02-08 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation for treating disorders
US7778711B2 (en) 2001-08-31 2010-08-17 Bio Control Medical (B.C.M.) Ltd. Reduction of heart rate variability by parasympathetic stimulation
US6934583B2 (en) 2001-10-22 2005-08-23 Pacesetter, Inc. Implantable lead and method for stimulating the vagus nerve
US6745079B2 (en) 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
US7155284B1 (en) 2002-01-24 2006-12-26 Advanced Bionics Corporation Treatment of hypertension
US6721603B2 (en) 2002-01-25 2004-04-13 Cyberonics, Inc. Nerve stimulation as a treatment for pain
AU2003217747A1 (en) 2002-02-26 2003-09-09 North Shore-Long Island Jewish Research Insitute Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
US7689276B2 (en) 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
US7937145B2 (en) 2002-03-22 2011-05-03 Advanced Neuromodulation Systems, Inc. Dynamic nerve stimulation employing frequency modulation
US7465555B2 (en) 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
US6978787B1 (en) 2002-04-03 2005-12-27 Michael Broniatowski Method and system for dynamic vocal fold closure with neuro-electrical stimulation
US20030191404A1 (en) 2002-04-08 2003-10-09 Klein George J. Method and apparatus for providing arrhythmia discrimination
US20050177200A1 (en) 2002-05-03 2005-08-11 George Mark S. Method, apparatus and system for determining effects and optimizing parameters of vagus nerve stimulation
US20050209654A1 (en) 2002-05-09 2005-09-22 Boveja Birinder R Method and system for providing adjunct (add-on) therapy for depression, anxiety and obsessive-compulsive disorders by providing electrical pulses to vagus nerve(s)
US20060079936A1 (en) 2003-05-11 2006-04-13 Boveja Birinder R Method and system for altering regional cerebral blood flow (rCBF) by providing complex and/or rectangular electrical pulses to vagus nerve(s), to provide therapy for depression and other medical disorders
US20050165458A1 (en) 2002-05-09 2005-07-28 Boveja Birinder R. Method and system to provide therapy for depression using electroconvulsive therapy(ECT) and pulsed electrical stimulation to vagus nerve(s)
US20060009815A1 (en) 2002-05-09 2006-01-12 Boveja Birinder R Method and system to provide therapy or alleviate symptoms of involuntary movement disorders by providing complex and/or rectangular electrical pulses to vagus nerve(s)
US20070067004A1 (en) 2002-05-09 2007-03-22 Boveja Birinder R Methods and systems for modulating the vagus nerve (10th cranial nerve) to provide therapy for neurological, and neuropsychiatric disorders
US7191012B2 (en) 2003-05-11 2007-03-13 Boveja Birinder R Method and system for providing pulsed electrical stimulation to a craniel nerve of a patient to provide therapy for neurological and neuropsychiatric disorders
US20050154426A1 (en) 2002-05-09 2005-07-14 Boveja Birinder R. Method and system for providing therapy for neuropsychiatric and neurological disorders utilizing transcranical magnetic stimulation and pulsed electrical vagus nerve(s) stimulation
US20050216070A1 (en) 2002-05-09 2005-09-29 Boveja Birinder R Method and system for providing therapy for migraine/chronic headache by providing electrical pulses to vagus nerve(s)
US8036745B2 (en) 2004-06-10 2011-10-11 Bio Control Medical (B.C.M.) Ltd. Parasympathetic pacing therapy during and following a medical procedure, clinical trauma or pathology
US7321793B2 (en) 2003-06-13 2008-01-22 Biocontrol Medical Ltd. Vagal stimulation for atrial fibrillation therapy
US20060116739A1 (en) 2002-05-23 2006-06-01 Nir Betser Electrode assembly for nerve control
US7277761B2 (en) 2002-06-12 2007-10-02 Pacesetter, Inc. Vagal stimulation for improving cardiac function in heart failure or CHF patients
US20040015202A1 (en) 2002-06-14 2004-01-22 Chandler Gilbert S. Combination epidural infusion/stimulation method and system
US20040015205A1 (en) 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US7292890B2 (en) 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US7203548B2 (en) 2002-06-20 2007-04-10 Advanced Bionics Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
KR100553516B1 (ko) 2002-06-24 2006-02-20 정종필 알파파유도 전기자극기
US20040049121A1 (en) 2002-09-06 2004-03-11 Uri Yaron Positioning system for neurological procedures in the brain
US7209790B2 (en) 2002-09-30 2007-04-24 Medtronic, Inc. Multi-mode programmer for medical device communication
AU2003301370A1 (en) 2002-10-15 2004-05-04 Medtronic Inc. Multi-modal operation of a medical device system
AU2003301255A1 (en) 2002-10-15 2004-05-04 Medtronic Inc. Screening techniques for management of a nervous system disorder
EP1558131A4 (en) 2002-10-15 2008-05-28 Medtronic Inc DELAYING THE RE-ADMINISTRATION OF A TREATMENT FOR A MEDICAL DEVICE SYSTEM
AU2003285888A1 (en) 2002-10-15 2004-05-04 Medtronic Inc. Medical device system with relaying module for treatment of nervous system disorders
AU2003284968A1 (en) 2002-10-25 2004-05-13 University Of South Florida Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
US20030229380A1 (en) 2002-10-31 2003-12-11 Adams John M. Heart failure therapy device and method
US7305265B2 (en) 2002-11-25 2007-12-04 Terumo Kabushiki Kaisha Heart treatment equipment for treating heart failure
US7142917B2 (en) 2002-12-04 2006-11-28 Terumo Kabushiki Kaisha Heart treatment equipment and method for preventing fatal arrhythmia
US7238715B2 (en) 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
JP4750421B2 (ja) 2002-12-06 2011-08-17 ノース ショア−ロング アイランド ジュ−イッシュ リサ−チ インスティチュ−ト α7受容体結合コリン作動性アゴニストを用いる炎症の阻害
US20040111139A1 (en) 2002-12-10 2004-06-10 Mccreery Douglas B. Apparatus and methods for differential stimulation of nerve fibers
TR200202651A2 (tr) 2002-12-12 2004-07-21 Met�N�Tulgar VücutÁdışındanÁdirekÁtedaviÁsinyaliÁtransferliÁÁbeyinÁpili
JP2004201901A (ja) 2002-12-25 2004-07-22 Yoshimi Kurokawa 胃電気刺激装置
WO2004064918A1 (en) 2003-01-14 2004-08-05 Department Of Veterans Affairs, Office Of General Counsel Cervical wagal stimulation induced weight loss
WO2004064729A2 (en) 2003-01-15 2004-08-05 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Treatments for snoring using injectable neuromuscular stimulators
US20050143781A1 (en) 2003-01-31 2005-06-30 Rafael Carbunaru Methods and systems for patient adjustment of parameters for an implanted stimulator
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7444183B2 (en) 2003-02-03 2008-10-28 Enteromedics, Inc. Intraluminal electrode apparatus and method
CN1964630A (zh) 2003-02-13 2007-05-16 耶希瓦大学艾伯塔·爱恩斯坦医学院 通过控制下丘脑的长链脂肪酰基-辅酶A(LC-CoA)的水平来调控食物摄取和葡萄糖产生
US7269455B2 (en) 2003-02-26 2007-09-11 Pineda Jaime A Method and system for predicting and preventing seizures
US7430449B2 (en) 2003-03-14 2008-09-30 Endovx, Inc. Methods and apparatus for testing disruption of a vagal nerve
US7783358B2 (en) 2003-03-14 2010-08-24 Endovx, Inc. Methods and apparatus for treatment of obesity with an ultrasound device movable in two or three axes
US6814418B2 (en) 2003-03-14 2004-11-09 D'orso Ronald Locker organizer
US20060015151A1 (en) 2003-03-14 2006-01-19 Aldrich William N Method of using endoscopic truncal vagoscopy with gastric bypass, gastric banding and other procedures
JP4252830B2 (ja) 2003-03-24 2009-04-08 テルモ株式会社 心臓治療装置
US7155279B2 (en) 2003-03-28 2006-12-26 Advanced Bionics Corporation Treatment of movement disorders with drug therapy
US7228167B2 (en) 2003-04-10 2007-06-05 Mayo Foundation For Medical Education Method and apparatus for detecting vagus nerve stimulation
US7706871B2 (en) 2003-05-06 2010-04-27 Nellcor Puritan Bennett Llc System and method of prediction of response to neurological treatment using the electroencephalogram
WO2004100765A2 (en) 2003-05-06 2004-11-25 Aspect Medical Systems, Inc. System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
DE10320863B3 (de) 2003-05-09 2004-11-11 Siemens Audiologische Technik Gmbh Befestigung eines Hörhilfegerätes oder einer Otoplastik im Ohr
US20050187590A1 (en) 2003-05-11 2005-08-25 Boveja Birinder R. Method and system for providing therapy for autism by providing electrical pulses to the vagus nerve(s)
US20050197678A1 (en) 2003-05-11 2005-09-08 Boveja Birinder R. Method and system for providing therapy for Alzheimer's disease and dementia by providing electrical pulses to vagus nerve(s)
US7444184B2 (en) 2003-05-11 2008-10-28 Neuro And Cardial Technologies, Llc Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s)
US20060074450A1 (en) 2003-05-11 2006-04-06 Boveja Birinder R System for providing electrical pulses to nerve and/or muscle using an implanted stimulator
US20060173508A1 (en) 2003-05-16 2006-08-03 Stone Robert T Method and system for treatment of eating disorders by means of neuro-electrical coded signals
US20060287679A1 (en) 2003-05-16 2006-12-21 Stone Robert T Method and system to control respiration by means of confounding neuro-electrical signals
US20060111755A1 (en) 2003-05-16 2006-05-25 Stone Robert T Method and system to control respiration by means of neuro-electrical coded signals
JP2007500576A (ja) 2003-05-16 2007-01-18 サイエンス・メディカス・インコーポレイテッド 神経電気コード化信号による呼吸制御
US20060064137A1 (en) 2003-05-16 2006-03-23 Stone Robert T Method and system to control respiration by means of simulated action potential signals
US7620454B2 (en) 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US7742818B2 (en) 2003-05-19 2010-06-22 Medtronic, Inc. Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof
US20100010603A1 (en) 2008-07-09 2010-01-14 Tamir Ben-David Electrode cuffs
JP4213522B2 (ja) 2003-05-30 2009-01-21 テルモ株式会社 心臓治療装置
US7738952B2 (en) 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
US7149574B2 (en) 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
WO2004110549A2 (en) * 2003-06-13 2004-12-23 Biocontrol Medical Ltd. Applications of vagal stimulation
EP1648560A4 (en) 2003-06-13 2015-10-28 Biocontrol Medical Ltd VAGAL STIMULATION FOR ANTI-EMBOLIC THERAPY
DE10328816A1 (de) 2003-06-21 2005-01-05 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Implantierbare Stimulationselektrode mit einer Beschichtung zur Erhöhung der Gewebsverträglichkeit
JP2007530417A (ja) 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞及び生物の寿命及びストレス応答を操作するための組成物
US7174218B1 (en) 2003-08-12 2007-02-06 Advanced Bionics Corporation Lead extension system for use with a microstimulator
JP4439215B2 (ja) 2003-08-26 2010-03-24 テルモ株式会社 心臓治療装置
US7263405B2 (en) 2003-08-27 2007-08-28 Neuro And Cardiac Technologies Llc System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities
US7797058B2 (en) 2004-08-04 2010-09-14 Ndi Medical, Llc Devices, systems, and methods employing a molded nerve cuff electrode
US20050070970A1 (en) 2003-09-29 2005-03-31 Knudson Mark B. Movement disorder stimulation with neural block
US20050070974A1 (en) 2003-09-29 2005-03-31 Knudson Mark B. Obesity and eating disorder stimulation treatment with neural block
US20050075702A1 (en) 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US7418292B2 (en) 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US20050153885A1 (en) 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
US7062320B2 (en) 2003-10-14 2006-06-13 Ehlinger Jr Philip Charles Device for the treatment of hiccups
AU2004283720A1 (en) 2003-10-24 2005-05-06 Medtronic, Inc. Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators
DE20316509U1 (de) 2003-10-27 2004-03-11 Lukl, Alfred Akupressur- und Massagegerät für das menschliche Ohr
US20050131467A1 (en) 2003-11-02 2005-06-16 Boveja Birinder R. Method and apparatus for electrical stimulation therapy for at least one of atrial fibrillation, congestive heart failure, inappropriate sinus tachycardia, and refractory hypertension
WO2005051451A2 (en) 2003-11-20 2005-06-09 Angiotech International Ag Electrical devices and anti-scarring agents
US20050137645A1 (en) 2003-12-05 2005-06-23 Juha Voipio Novel method for the adjustment of human and animal vagus nerve stimulation
US7769461B2 (en) 2003-12-19 2010-08-03 Boston Scientific Neuromodulation Corporation Skull-mounted electrical stimulation system and method for treating patients
US7486991B2 (en) 2003-12-24 2009-02-03 Cardiac Pacemakers, Inc. Baroreflex modulation to gradually decrease blood pressure
US20050149129A1 (en) 2003-12-24 2005-07-07 Imad Libbus Baropacing and cardiac pacing to control output
US7460906B2 (en) 2003-12-24 2008-12-02 Cardiac Pacemakers, Inc. Baroreflex stimulation to treat acute myocardial infarction
US7422555B2 (en) 2003-12-30 2008-09-09 Jacob Zabara Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
WO2005089646A1 (en) 2004-03-16 2005-09-29 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US7255675B2 (en) 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
EP1734941A2 (en) 2004-03-25 2006-12-27 The Feinstein Institute for Medical Research Neural tourniquet
EP1750799A2 (en) 2004-05-04 2007-02-14 The Cleveland Clinic Foundation Methods of treating medical conditions by neuromodulation of the sympathetic nervous system
US20060111644A1 (en) 2004-05-27 2006-05-25 Children's Medical Center Corporation Patient-specific seizure onset detection system
JP2008501343A (ja) 2004-06-04 2008-01-24 ワシントン・ユニバーシティ 神経障害を治療するための方法および組成物
US7565197B2 (en) 2004-06-18 2009-07-21 Medtronic, Inc. Conditional requirements for remote medical device programming
US7664551B2 (en) 2004-07-07 2010-02-16 Medtronic Transneuronix, Inc. Treatment of the autonomic nervous system
US7711432B2 (en) 2004-07-26 2010-05-04 Advanced Neuromodulation Systems, Inc. Stimulation system and method for treating a neurological disorder
US20060025828A1 (en) 2004-07-28 2006-02-02 Armstrong Randolph K Impedance measurement for an implantable device
US7204815B2 (en) 2004-08-11 2007-04-17 Georgia K. Connor Mastoid ear cuff and system
US8452407B2 (en) 2004-08-16 2013-05-28 Boston Scientific Neuromodulation Corporation Methods for treating gastrointestinal disorders
US20050154425A1 (en) 2004-08-19 2005-07-14 Boveja Birinder R. Method and system to provide therapy for neuropsychiatric disorders and cognitive impairments using gradient magnetic pulses to the brain and pulsed electrical stimulation to vagus nerve(s)
US7337006B2 (en) 2004-09-08 2008-02-26 Spinal Modulation, Inc. Methods and systems for modulating neural tissue
WO2006045054A2 (en) 2004-10-18 2006-04-27 E-Soc Device for neuromusclar, peripheral body stimulation and electrical stimulation (es) for wound healing using rf energy harvesting
WO2006047264A1 (en) 2004-10-21 2006-05-04 Advanced Neuromodulation Systems, Inc. Peripheral nerve stimulation to treat auditory dysfunction
US7672733B2 (en) 2004-10-29 2010-03-02 Medtronic, Inc. Methods and apparatus for sensing cardiac activity via neurological stimulation therapy system or medical electrical lead
US7818342B2 (en) 2004-11-12 2010-10-19 Sap Ag Tracking usage of data elements in electronic business communications
US8332047B2 (en) 2004-11-18 2012-12-11 Cardiac Pacemakers, Inc. System and method for closed-loop neural stimulation
US9089691B2 (en) 2004-12-07 2015-07-28 Cardiac Pacemakers, Inc. Stimulator for auricular branch of vagus nerve
US7366571B2 (en) 2004-12-10 2008-04-29 Cyberonics, Inc. Neurostimulator with activation based on changes in body temperature
US20060161217A1 (en) 2004-12-21 2006-07-20 Jaax Kristen N Methods and systems for treating obesity
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
WO2006073484A2 (en) 2004-12-27 2006-07-13 North Shore-Long Island Jewish Research Institute Treating inflammatory disorders by electrical vagus nerve stimulation
JP2008527002A (ja) 2005-01-13 2008-07-24 サートリス ファーマシューティカルズ, インコーポレイテッド 神経変性障害および血液凝固障害を予防および処置するための新規組成物
US8825166B2 (en) 2005-01-21 2014-09-02 John Sasha John Multiple-symptom medical treatment with roving-based neurostimulation
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US8609082B2 (en) 2005-01-25 2013-12-17 Bio Control Medical Ltd. Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
DE102005003735B4 (de) 2005-01-26 2008-04-03 Cerbomed Gmbh Vorrichtung zur transkutanen Stimulation eines Nervs des menschlichen Körpers
US8600521B2 (en) 2005-01-27 2013-12-03 Cyberonics, Inc. Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity
US7561918B2 (en) 2005-01-28 2009-07-14 Cyberonics, Inc. Autocapture in a neurostimulator
US20060173493A1 (en) 2005-01-28 2006-08-03 Cyberonics, Inc. Multi-phasic signal for stimulation by an implantable device
EP1846094B1 (en) 2005-02-02 2011-10-05 NuVasive, Inc. System for performing neurophysiologic assessments during surgery
EP1848820A2 (en) 2005-02-08 2007-10-31 Janssen Pharmaceutica N.V. Vagal afferent neurons as targets for treatment
US8185199B2 (en) 2005-02-10 2012-05-22 Zoll Medical Corporation Monitoring physiological signals during external electrical stimulation
US7548780B2 (en) 2005-02-22 2009-06-16 Cardiac Pacemakers, Inc. Cell therapy and neural stimulation for cardiac repair
US20060200219A1 (en) 2005-03-01 2006-09-07 Ndi Medical, Llc Systems and methods for differentiating and/or identifying tissue regions innervated by targeted nerves for diagnostic and/or therapeutic purposes
US8700163B2 (en) 2005-03-04 2014-04-15 Cyberonics, Inc. Cranial nerve stimulation for treatment of substance addiction
US7613511B2 (en) 2005-03-09 2009-11-03 Cardiac Pacemakers, Inc. Implantable vagal stimulator for treating cardiac ischemia
US20060229681A1 (en) 2005-04-11 2006-10-12 Fischell Robert E Implantable system for the treatment of atrial fibrillation
US7499748B2 (en) 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
US7881782B2 (en) 2005-04-20 2011-02-01 Cardiac Pacemakers, Inc. Neural stimulation system to prevent simultaneous energy discharges
US20060282121A1 (en) 2005-04-25 2006-12-14 Payne Bryan R Vagus nerve stimulation for chronic intractable hiccups
US7310557B2 (en) 2005-04-29 2007-12-18 Maschino Steven E Identification of electrodes for nerve stimulation in the treatment of eating disorders
US7835796B2 (en) 2005-04-29 2010-11-16 Cyberonics, Inc. Weight loss method and device
US7899540B2 (en) 2005-04-29 2011-03-01 Cyberonics, Inc. Noninvasively adjustable gastric band
US7734348B2 (en) 2005-05-10 2010-06-08 Cardiac Pacemakers, Inc. System with left/right pulmonary artery electrodes
US7765000B2 (en) 2005-05-10 2010-07-27 Cardiac Pacemakers, Inc. Neural stimulation system with pulmonary artery lead
US7617003B2 (en) 2005-05-16 2009-11-10 Cardiac Pacemakers, Inc. System for selective activation of a nerve trunk using a transvascular reshaping lead
US20060292099A1 (en) 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US7584004B2 (en) 2005-06-13 2009-09-01 Cardiac Pacemakers, Inc. Vascularly stabilized peripheral nerve cuff assembly
US8036750B2 (en) 2005-06-13 2011-10-11 Cardiac Pacemakers, Inc. System for neural control of respiration
US20060293721A1 (en) 2005-06-28 2006-12-28 Cyberonics, Inc. Vagus nerve stimulation for treatment of depression with therapeutically beneficial parameter settings
US20070016262A1 (en) 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US7711419B2 (en) 2005-07-13 2010-05-04 Cyberonics, Inc. Neurostimulator with reduced size
US8140159B2 (en) 2005-07-21 2012-03-20 Cyberonics, Inc. Safe-mode operation of an implantable medical device
US20070021786A1 (en) 2005-07-25 2007-01-25 Cyberonics, Inc. Selective nerve stimulation for the treatment of angina pectoris
US20070027497A1 (en) 2005-07-27 2007-02-01 Cyberonics, Inc. Nerve stimulation for treatment of syncope
US20070027504A1 (en) 2005-07-27 2007-02-01 Cyberonics, Inc. Cranial nerve stimulation to treat a hearing disorder
US7840280B2 (en) 2005-07-27 2010-11-23 Cyberonics, Inc. Cranial nerve stimulation to treat a vocal cord disorder
US20070027484A1 (en) 2005-07-28 2007-02-01 Cyberonics, Inc. Autonomic nerve stimulation to treat a pancreatic disorder
US7856273B2 (en) 2005-07-28 2010-12-21 Cyberonics, Inc. Autonomic nerve stimulation to treat a gastrointestinal disorder
US8660647B2 (en) 2005-07-28 2014-02-25 Cyberonics, Inc. Stimulating cranial nerve to treat pulmonary disorder
US7706874B2 (en) 2005-07-28 2010-04-27 Cyberonics, Inc. Stimulating cranial nerve to treat disorders associated with the thyroid gland
US7499752B2 (en) 2005-07-29 2009-03-03 Cyberonics, Inc. Selective nerve stimulation for the treatment of eating disorders
US20070025608A1 (en) 2005-07-29 2007-02-01 Cyberonics, Inc. Enhancing intrinsic neural activity using a medical device to treat a patient
US20070027499A1 (en) 2005-07-29 2007-02-01 Cyberonics, Inc. Neurostimulation device for treating mood disorders
US7532935B2 (en) 2005-07-29 2009-05-12 Cyberonics, Inc. Selective neurostimulation for treating mood disorders
EP1910384B1 (en) 2005-08-04 2012-10-10 Sirtris Pharmaceuticals, Inc. Imidazo [2,1-b]thiazole derivatives as sirtuin modulating compounds
US7672727B2 (en) 2005-08-17 2010-03-02 Enteromedics Inc. Neural electrode treatment
US7822486B2 (en) 2005-08-17 2010-10-26 Enteromedics Inc. Custom sized neural electrodes
US7860566B2 (en) 2005-10-06 2010-12-28 The Cleveland Clinic Foundation System and method for achieving regular slow ventricular rhythm in response to atrial fibrillation
US7856264B2 (en) 2005-10-19 2010-12-21 Advanced Neuromodulation Systems, Inc. Systems and methods for patient interactive neural stimulation and/or chemical substance delivery
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US20070100263A1 (en) 2005-10-27 2007-05-03 Merfeld Daniel M Mechanical actuator for a vestibular stimulator
US7957796B2 (en) 2005-10-28 2011-06-07 Cyberonics, Inc. Using physiological sensor data with an implantable medical device
US20070100377A1 (en) 2005-10-28 2007-05-03 Cyberonics, Inc. Providing multiple signal modes for a medical device
US7555344B2 (en) 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
EP1948301B8 (en) 2005-11-10 2014-03-12 ElectroCore LLC Electrical stimulation treatment of bronchial constriction
US8812112B2 (en) 2005-11-10 2014-08-19 ElectroCore, LLC Electrical treatment of bronchial constriction
US7630760B2 (en) 2005-11-21 2009-12-08 Cardiac Pacemakers, Inc. Neural stimulation therapy system for atherosclerotic plaques
US7596414B2 (en) 2005-12-05 2009-09-29 Boston Scientific Neuromodulation Corporation Cuff electrode arrangement for nerve stimulation and methods of treating disorders
US7570999B2 (en) 2005-12-20 2009-08-04 Cardiac Pacemakers, Inc. Implantable device for treating epilepsy and cardiac rhythm disorders
US20070150027A1 (en) 2005-12-22 2007-06-28 Rogers Lesco L Non-invasive device and method for electrical stimulation of neural tissue
US9566447B2 (en) 2005-12-28 2017-02-14 Cardiac Pacemakers, Inc. Neural stimulation system for reducing atrial proarrhythmia
US7672728B2 (en) 2005-12-28 2010-03-02 Cardiac Pacemakers, Inc. Neural stimulator to treat sleep disordered breathing
US7610100B2 (en) 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7467016B2 (en) 2006-01-27 2008-12-16 Cyberonics, Inc. Multipolar stimulation electrode with mating structures for gripping targeted tissue
US20090105782A1 (en) 2006-03-15 2009-04-23 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Vagus nerve stimulation apparatus, and associated methods
JP5415255B2 (ja) 2006-03-29 2014-02-12 ディグニティー ヘルス 病状治療用の脳神経マイクロバースト電気刺激
US7974706B2 (en) 2006-03-30 2011-07-05 Boston Scientific Neuromodulation Corporation Electrode contact configurations for cuff leads
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
US20070255320A1 (en) 2006-04-28 2007-11-01 Cyberonics, Inc. Method and apparatus for forming insulated implantable electrodes
US20070255333A1 (en) 2006-04-28 2007-11-01 Medtronic, Inc. Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
US7962220B2 (en) 2006-04-28 2011-06-14 Cyberonics, Inc. Compensation reduction in tissue stimulation therapy
WO2007133718A2 (en) 2006-05-11 2007-11-22 Neurometrix, Inc Non-invasive acquisition of large nerve action potentials (naps) with closely spaced surface electrodes and reduced stimulus artifacts
US8712529B2 (en) 2010-03-05 2014-04-29 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US8214056B2 (en) 2006-06-02 2012-07-03 Neurostream Technologies General Partnership Nerve cuff, method and apparatus for manufacturing same
DE102006033623B4 (de) 2006-07-18 2010-04-08 Cerbomed Gmbh System zur transkutanen Stimulation eines Nervs des menschlichen Körpers
DE102006036069B4 (de) 2006-07-18 2008-09-04 Cerbomed Gmbh Audiologisches Übertragungssystem
US7996088B2 (en) 2006-07-26 2011-08-09 Cyberonics, Inc. Vagus nerve stimulation by electrical signals for controlling cerebellar tremor
US8868211B2 (en) 2006-08-15 2014-10-21 Case Western Reserve University Nerve cuff for implantable electrode
US7738961B2 (en) 2006-10-09 2010-06-15 Endostim, Inc. Method and apparatus for treatment of the gastrointestinal tract
DE202007019439U1 (de) 2006-10-13 2012-09-12 Apnex Medical, Inc. Geräte, Systeme und Methoden zur Behandlung von obstruktiver Schalfapnoe
US7729760B2 (en) 2006-10-27 2010-06-01 Cyberonics, Inc. Patient management system for providing parameter data for an implantable medical device
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US7996092B2 (en) 2007-01-16 2011-08-09 Ndi Medical, Inc. Devices, systems, and methods employing a molded nerve cuff electrode
US7706875B2 (en) 2007-01-25 2010-04-27 Cyberonics, Inc. Modulation of drug effects by vagus nerve stimulation
US20080183246A1 (en) 2007-01-26 2008-07-31 Cyberonics, Inc. Method, apparatus and system for guiding a procedure relating to an implantable medical device
US7974707B2 (en) 2007-01-26 2011-07-05 Cyberonics, Inc. Electrode assembly with fibers for a medical device
US8068918B2 (en) 2007-03-09 2011-11-29 Enteromedics Inc. Remote monitoring and control of implantable devices
CA2680477A1 (en) 2007-03-13 2008-09-18 The Feinstein Institute For Medical Research Treatment of inflammation by non-invasive stimulation
US7819883B2 (en) 2007-03-13 2010-10-26 Cardiac Pacemakers, Inc. Method and apparatus for endoscopic access to the vagus nerve
JP2010524432A (ja) 2007-03-19 2010-07-22 サートリス ファーマシューティカルズ, インコーポレイテッド サーチュイン活性のバイオマーカーおよびその使用方法
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
US20080281365A1 (en) 2007-05-09 2008-11-13 Tweden Katherine S Neural signal duty cycle
CL2008001821A1 (es) 2007-06-20 2009-03-13 Sirtris Pharmaceuticals Inc Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras.
US20090012590A1 (en) 2007-07-03 2009-01-08 Cyberonics, Inc. Neural Conductor
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
WO2009027755A1 (en) 2007-08-28 2009-03-05 Institut National De La Recherche Agronomique (Inra) Device and method for reducing weight
US20090082832A1 (en) 2007-09-25 2009-03-26 Boston Scientific Neuromodulation Corporation Thermal Management of Implantable Medical Devices
US8019419B1 (en) 2007-09-25 2011-09-13 Dorin Panescu Methods and apparatus for leadless, battery-less, wireless stimulation of tissue
US8942798B2 (en) 2007-10-26 2015-01-27 Cyberonics, Inc. Alternative operation mode for an implantable medical device based upon lead condition
US9089707B2 (en) 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
US8165668B2 (en) 2007-12-05 2012-04-24 The Invention Science Fund I, Llc Method for magnetic modulation of neural conduction
US8195287B2 (en) 2007-12-05 2012-06-05 The Invention Science Fund I, Llc Method for electrical modulation of neural conduction
US8180446B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method and system for cyclical neural modulation based on activity state
CN201230913Y (zh) 2007-12-06 2009-05-06 崔树森 自体功能性放大的人工神经导管
WO2009097542A2 (en) 2008-01-30 2009-08-06 Board Of Regents Of The University Of Texas System Ileal electrical stimulation
US9014801B2 (en) 2008-03-19 2015-04-21 The Board Of Trustees Of The University Of Illinois Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
EP3047874B1 (en) 2008-04-04 2022-03-09 ReShape Lifesciences Inc. Systems for glucose regulation and methods of making such systems
US20090275997A1 (en) 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
AU2009316801C1 (en) 2008-11-18 2015-12-24 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflammatory stimulation
US20100191304A1 (en) 2009-01-23 2010-07-29 Scott Timothy L Implantable Medical Device for Providing Chronic Condition Therapy and Acute Condition Therapy Using Vagus Nerve Stimulation
US20110054569A1 (en) 2009-09-01 2011-03-03 Zitnik Ralph J Prescription pad for treatment of inflammatory disorders
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
WO2010144578A2 (en) 2009-06-09 2010-12-16 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208266A1 (en) * 2003-07-18 2008-08-28 The Johns Hopkins University System and Method for Treating Nausea and Vomiting by Vagus Nerve Stimulation
CN101528303A (zh) * 2006-08-29 2009-09-09 心脏起搏器股份公司 用于神经刺激的系统
CN101868280A (zh) * 2007-09-25 2010-10-20 心脏起搏器股份公司 用于心脏病症的神经刺激系统
WO2010005482A1 (en) * 2008-07-08 2010-01-14 Cardiac Pacemakers, Inc. Systems for delivering vagal nerve stimulation
WO2010067360A2 (en) * 2008-12-09 2010-06-17 Nephera Ltd. Stimulation of the urinary system
US20110190849A1 (en) * 2009-12-23 2011-08-04 Faltys Michael A Neural stimulation devices and systems for treatment of chronic inflammation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11766560B2 (en) 2010-04-01 2023-09-26 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US11730953B2 (en) 2014-08-27 2023-08-22 Aleva Neurotherapeutics Deep brain stimulation lead
CN108290041A (zh) * 2015-04-24 2018-07-17 伽尔伐尼生物电子有限公司 神经调节设备
CN109069824A (zh) * 2016-02-02 2018-12-21 阿莱瓦神经治疗股份有限公司 使用深部脑刺激治疗自身免疫疾病
US11266830B2 (en) 2018-03-02 2022-03-08 Aleva Neurotherapeutics Neurostimulation device
US11738192B2 (en) 2018-03-02 2023-08-29 Aleva Neurotherapeutics Neurostimulation device

Also Published As

Publication number Publication date
EP2707094A2 (en) 2014-03-19
EP2707094B1 (en) 2016-02-03
US20120290035A1 (en) 2012-11-15
US8788034B2 (en) 2014-07-22
WO2012154865A3 (en) 2013-01-31
WO2012154865A2 (en) 2012-11-15
CN103619405B (zh) 2015-11-25
EP2707094A4 (en) 2014-11-26

Similar Documents

Publication Publication Date Title
CN103619405B (zh) 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活
US10207109B2 (en) System for combining electrical waveforms into a combined electrical waveform
US9211410B2 (en) Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9694183B2 (en) Neuromodulation system and method for providing multiple modulation patterns in a single channel
ES2735624T3 (es) Neuroestimulador implantable para el control de la bradicardia a través de la estimulación del nervio vago
AU2014218709B2 (en) Multi-channel neuromodulation system with means for combining pulse trains
US20170216598A1 (en) Reversing recruitment order by anode intensification
US9037261B2 (en) Method for improving far-field activation in peripheral field nerve stimulation
CN108653915A (zh) 伴随减少能量的多电极刺激治疗
JP2017505195A (ja) 変調閾値以下治療を患者に行うシステム及び方法
JP2015509817A (ja) 電圧源を使用したフィールド増強式電流ステアリング
WO2020128748A1 (en) Nerve stimulation system
US20140200622A1 (en) Combination Device and Methods for Treating Congestive Heart Failure and Stroke
AU2012253575B2 (en) Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
AU2012253575A1 (en) Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
WO2010027993A3 (en) Systems for stimulation of the cholinergic anti-inflammatory pathway via a superior vena cava lead

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant